Skip to main content
Equibles

WELLS FARGO & COMPANY/MN

Position in VIR — Vir Biotechnology, Inc.

CIK 72971 SAN FRANCISCO, CA
Back to VIR Full portfolio

Position in VIR

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$1,164,400
+$792,015 QoQ
Shares Held
114,269
+174.9% QoQ
Ownership
0.068%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#89
of 237 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority Sole 96% Shared 0% None 4%

Common Shares in VIR Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

WELLS FARGO & COMPANY/MN holds $1,575,562,942 across 417 Biotechnology names. VIR ranks #129 (0.1% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 VRTX
Vertex Pharmaceuticals Inc / Ma
 749,528 $372,313,040
2 HALO
Halozyme Therapeutics, Inc.
 1,390,428 $108,828,797
3 ALNY
Alnylam Pharmaceuticals, Inc.
 310,047 $93,333,446
4 REGN
Regeneron Pharmaceuticals, Inc.
 140,802 $87,795,677
5 EXEL
Exelixis, Inc.
 717,840 $39,057,673
6 RVMD
Revolution Medicines, Inc.
 178,780 $33,481,916
7 ARGX
Argenx SE
 34,453 $31,964,458
8 INCY
Incyte Corp
 255,064 $28,914,053

All Filings in VIR

Export CSV
26 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $1,164,400 114,269
2026-03-31 $372,385 41,561
2025-12-31 $635,633 105,412
2025-09-30 $430,790 75,445
2025-06-30 $313,321 62,167
2025-03-31 $365,679 56,432
2024-12-31 $386,531 52,661
2024-09-30 $1,885,659 251,757
2024-06-30 $377,501 42,416
2024-03-31 $301,832 29,796
2023-12-31 $261,809 26,025
2023-09-30 $1,091,303 116,468
2023-06-30 $2,218,491 90,440
2023-03-31 $1,631,854 70,127
2022-12-31 $159,526 6,303
2022-09-30 $219,077 11,363
2022-06-30 $324,690 12,748
2022-03-31 $1,085,870 42,219
2021-12-31 $2,519,818 60,182
2021-09-30 $2,635,526 60,559
2021-06-30 $841,488 17,798
2021-03-31 $1,154,034 22,509
2020-12-31 $2,680,970 100,111
2020-09-30 $1,419,200 41,340
2020-06-30 $2,770,964 67,634
2020-03-31 $409,869 11,960